Nanodrug potential in cancer therapy: efficacy/toxicity studies in cancer cells
by Alessandra Pagano; Stéphane Honoré; Marie-Anne Estève; Diane Braguer
International Journal of Nanotechnology (IJNT), Vol. 9, No. 3/4/5/6/7, 2012

Abstract: The interest of nanotechnology to find a more effective approach for drug delivery is growing fast. Nanoparticles as drug vehicles potentially improve the pharmacokinetic and pharmacodynamic properties of various types of drugs, and provide a tool to visualise molecules and tumour target cells that otherwise cannot be detected through conventional imaging. However, there are many aspects of nanoparticle formulation, characterisation and their effect on delivery of drugs and therapeutics that remain to be explored. This review summarises the main characteristics of nanoparticles for drug delivery in cancer treatment, and describes an experimental approach for evaluating efficacy and toxicity of nanocarriers in cancer cells.

Online publication date: Mon, 06-Feb-2012

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com